TUCSON, Ariz., Dec. 8, 2020 /PRNewswire/ -- Procyon Technologies LLC today announced that it has entered into an exclusive research collaboration and license agreement with Novo Nordisk A/S to develop ...

Tampa, Fla. (Jan. 21, 2009) – Early attempts at islet cell transplantation to treat diabetes date to the nineteenth century, decades before the discovery of insulin in the 1930s. In recent years, ...

A collaboration between researchers from Cornell and University of Alberta, Edmonton, has created a new technique to treat type 1 diabetes: implanting a device inside a pocket under the skin that can ...

Scientists have developed a new implantable device that has the potential to change the way Type 1 diabetics receive insulin. The thread-like implant, or SHEATH (Subcutaneous Host-Enabled Alginate ...

CHICAGO — Ten people with type 1 diabetes, who had recurrent severe hypoglycemia and hypoglycemic unawareness, have remained insulin-independent for over a year following allogeneic stem cell-derived ...

The need to avoid immunosuppression is often the driving force behind research into alternative therapeutic options for the treatment of a range of diseases. One such disease is type I diabetes, which ...

SAN DIEGO, April 17, 2018 /PRNewswire/ -- ViaCyte, Inc., a privately-held regenerative medicine company, today announced the recent issuance of more than 200 patents, which provide protection to the ...

JDRF, in collaboration with The Leona M. and Harry B. Helmsley Charitable Trust (HCT), announced today that it has finalized a grant in the area of islet cell encapsulation to Dr. Camillo Ricordi, M.D ...

ITHACA, N.Y. - For the more than 1 million Americans who live with type 1 diabetes, daily insulin injections are literally a matter of life and death. And while there is no cure, a Cornell ...